News

GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical-stage biotechnology company specializing in glycan-directed ...
Nona Biosciences, a global biotechnology company providing integrated solutions from 'Idea to IND' (I to ITM), today ...
The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...
A recent serosurvey in Tamil Nadu reveals 97% of elderly have Covid-19 antibodies. The report indicates widespread immunity.
MacroGenics' recent royalty deal extends cash runway, but liquidity concerns remain, and further asset sales or dilution may ...
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...
The agreement has been designed to offer a turnkey service to companies seeking faster time to market.
Fast Track Designation (FTD) granted for the treatment of patients with metastatic PDAC with high IL1RAP expression levels.Reflects high unmet medical need in metastatic PDAC.Facilitates further devel ...
Why do people develop antibodies to food? While clinicians have long observed that healthy humans develop a particular type ...
Results from a first-in-human Phase Ia/Ib trial show that LY4170156 demonstrated a notably high overall response rate in ...
A breakthrough treatment has allowed damaged retinal cells to regenerate themselves. The current research has been conducted ...